<DOC>
	<DOCNO>NCT00517101</DOCNO>
	<brief_summary>A relationship IBD spondyloarthropathy well recognize . ASCA ( anti saccharomyces cerevisiae antibody ) consider serological marker Crohn 's disease study patient spondyloarthropathy conflict result . More recently , new serological marker IBD describe . These marker antibody certain defined glycans , use may permit improved diagnosis IBD . The aim study investigate wether new serological marker present serum patient spondyloarthropathy .</brief_summary>
	<brief_title>Presence IBD Specific Antibodies ( ASCA , ALCA , ACCA , AMCA ) Sera Patients With Spondyloarthropathy</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Spondylarthropathies</mesh_term>
	<mesh_term>Spondylarthritis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>diagnosis psoriatic arthritis , ankylose spondylitis , undifferentiated spondyloarthropathy diagnose inflammatory bowel disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>spondyloarthropathy</keyword>
	<keyword>inflammatory bowel disease</keyword>
	<keyword>antibody</keyword>
</DOC>